At the recent Advances in Genome Biology and Technology (AGBT) conference, Roche unveiled its SBX (Sequencing by Expansion) technology, developed by Stratos Genomics, a Seattle-based company Roche acquired in 2020. First teased in a pre-AGBT webinar, SBX could significantly impact the DNA sequencing market. Biotech investor Joe Horsman of Madrona Venture Group explores the technology’s unexpected origins, how it works, and its potential.
